Former FDA Chief Cites 5 Things To Watch On Drug Approvals And Keeping Drugs Safe

1. Faster drug approvals, being advocated by Trump and others, don’t necessarily mean less expensive drugs.
2. A law passed in December should streamline drug approvals — in a positive way.
3. But Califf has concerns about maintaining drug safety standards and ensuring thorough clinical trials.
4. Faster, better drugs can’t be approved if the FDA is understaffed, he argued.
5. The FDA is using big data to track the safety of drugs already on the market — and it plans to do that a lot more.

Source: KHN
Source URL: http://khn.org/news/former-fda-chief-cites-5-things-to-watch...

Printer-friendly versionSend to friendmore...